Transcription factor-kappa B (NF-kappa B) and renal disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Kidney International

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.2001.059002415.XPMID 11168923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diphenyleneiodium Chloride Blocks Inflammatory Cytokine-Induced Up-Regulation of Group IIA Phospholipase A2 in Rat Mesangial Cells

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Role and regulation of apoptotic cell death in the kidney. Y2K update.

  2000cited by this paper
• Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms.

  2000cited by this paper
• Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells.

  2000cited by this paper
• Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.

  2000cited by this paper
• Administration of IgG Fc Fragments Prevents Glomerular Injury in Experimental Immune Complex Nephritis1

  2000cited by this paper
• Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells.

  2000cited by this paper
• Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.

  1999cited by this paper
• The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus

  1999cited by this paper
• The mitogen-activated protein kinase p38 is necesssary for interleukin 1beta-induced monocyte chemoattractant protein 1 expression by human mesangial cells.

  1999cited by this paper
• Induction of Monocyte Chemoattractant Protein-1 by Albumin Is Mediated by Nuclear Factor κB in Proximal Tubule Cells

  1999cited by this paper
• Transcriptional Activation by NF-κB Requires Multiple Coactivators

  1999cited by this paper
• Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats

  1999cited by this paper
• Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.

  1999cited by this paper
• Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction.

  1999cited by this paper
• In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry.

  1999cited by this paper
• Insulin Antiapoptotic Signaling Involves Insulin Activation of the Nuclear Factor κB-dependent Survival Genes Encoding Tumor Necrosis Factor Receptor-associated Factor 2 and Manganese-superoxide Dismutase*

  1999cited by this paper
• Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells.

  1999cited by this paper
• Transcriptional regulation of the interleukin-6 gene in mesangial cells.

  1999cited by this paper
• The PEST Domain of IκBα Is Necessary and Sufficient forin Vitro Degradation by μ-Calpain*

  1999cited by this paper
• Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.

  1999cited by this paper
• Activation of NF-kappaB in normal rat kidney epithelial (NRK52E) cells is mediated via a redox-insensitive, calcium-dependent pathway.

  1999cited by this paper
• Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression.

  1999cited by this paper
• Proteasome inhibition: A novel mechanism to combat asthma.

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Transcriptional activation by NF-kappaB requires multiple coactivators.

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Selective Sensitization to Tumor Necrosis Factor-α-induced Apoptosis by Blockade of NF-κB in Primary Glomerular Mesangial Cells*

  1999cited by this paper
• THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLS

  1999cited by this paper
• The central role of nuclear factor-κB in mesangial cell activation

  1999cited by this paper
• The central role of nuclear factor-kappa B in mesangial cell activation.

  1999cited by this paper
• Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells.

  1999cited by this paper
• Mechanisms of Hyaluronan-Induced Up-Regulation of ICAM-1 and VCAM-1 Expression by Murine Kidney Tubular Epithelial Cells: Hyaluronan Triggers Cell Adhesion Molecule Expression Through a Mechanism Involving Activation of Nuclear Factor-κB and Activating Protein-1

  1998cited by this paper
• Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis.

  1998cited by this paper
• Calmodulin dependence of NFkappaB activation.

  1998cited by this paper
• Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction.

  1998cited by this paper
• Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells.

  1998cited by this paper
• IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis.

  1998cited by this paper
• Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris.

  1998cited by this paper
• Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.

  1998cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.

  1998cited by this paper
• ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.

  1998cited by this paper
• Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation.

  1998cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.

  1998cited by this paper
• Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.

  1998cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.

  1998cited by this paper
• Nuclear Factor-κB Is Selectively and Markedly Activated in Humans With Unstable Angina Pectoris

  1998cited by this paper
• Calmodulin dependence of NFκB activation

  1998cited by this paper
• IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival

  1998cited by this paper
• Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1.

  1998cited by this paper
• Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation

  1997cited by this paper
• Role of NFkappaB in the mortality of sepsis.

  1997cited by this paper
• A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.

  1997cited by this paper
• Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.

  1997cited by this paper
• Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status.

  1997cited by this paper
• Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10.

  1997cited by this paper
• Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• Interleukin-1β Induction of Mitogen-activated Protein Kinases in Human Mesangial Cells

  1997cited by this paper
• Cysteine S-conjugates activate transcription factor NF-kappa B in cultured renal epithelial cells.

  1997cited by this paper
• Cyclosporin A interferes with the inducible degradation of NF‐xB inhibitors, but not with the processing of p105/NF‐xB1 in T cells

  1997cited by this paper
• N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo.

  1997cited by this paper
• Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction: Rapid Communication

  1997cited by this paper
• Suppression by cyclosporin A of interleukin 1β‐induced expression of group II phospholipase A2 in rat renal mesangial cells

  1997cited by this paper
• Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action.

  1997cited by this paper
• Central role of the transcription factor nuclear factor-kappa B in mesangial cell production of chemokines.

  1997cited by this paper
• A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

  1997cited by this paper
• Regulation of mesangial cell proliferation by the mevalonate pathway.

  1997cited by this paper
• Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring.

  1997cited by this paper
• The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis*

  1997cited by this paper
• Role of nuclear factor‐kappa B in atherogenesis

  1997cited by this paper
• Tyrosine Phosphorylation of I?B-a Activates NF-?B without Proteolytic Degradation of I?B-a

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

  1996cited by this paper
• Cyclosporine a inhibits tissue factor expression in monocytes/macrophages.

  1996cited by this paper
• IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

  1996cited by this paper
• Tyrosine Kinase Inhibitors, Genistein and Herbimycin A, Do Not Block Interleukin-1 β-Induced Activation of NF-κB in Rat Mesangial Cells

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

  1996cited by this paper
• An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

  1996cited by this paper
• Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

  1996cited by this paper
• Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats.

  1996cited by this paper
• Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells.

  1996cited by this paper
• TRAF6 is a signal transducer for interleukin-1.

  1996cited by this paper
• TRAF6 is a signal transducer for interleukin-1

  1996cited by this paper
• Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.

  1996cited by this paper
• Suppression of TNF-α-Induced Apoptosis by NF-κB

  1996cited by this paper
• TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

  1996cited by this paper
• Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1 beta-induced activation of NF-kappa B in rat mesangial cells.

  1996cited by this paper
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death

  1996cited by this paper
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

  1996cited by this paper

• Erythropoietin and Ferulic Acid Loaded on Fe3O4 Nanoparticles Exert Therapeutic Effect against Acute Kidney Injury Induced by Cisplatin Via Bcl-2/Bax, IL-6, TGF-β, and GPX-4 Mechanisms.

  2026cites this paper
• The ameliorative effect of inhibiting Transient Receptor Potential Ankyrin 1 on sepsis-induced kidney injury via the toll-like receptor 4/nuclear factor-kappa B pathway.

  2025cites this paper
• Different Translational Activities of Inflammatory Regulators Associated with Hypervolemia in Haemodialysis Patients

  2025cites this paper
• Core–shell nanofibers for localized melanoma therapy delivering Pioglitazone nanoemulsions and gemcitabine dual loaded system

  2025cites this paper
• Investigation of The Protective and Preventive Effect of Vitamin C Against the Toxic Effect of Dexketoprofen Trometamol on Rat Kidney

  2025cites this paper
• Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease

  2025cites this paper
• HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylation.

  2025cites this paper
• Protective Effect of Transient Receptor Potential Ankyrin 1 Inhibition on Renal Ischemia Reperfusion Injury in Rats

  2025cites this paper
• Niaodukang for the treatment of chronic kidney disease: Regulation of the TRAF3/NF-κB2 signaling pathway and its improvement of the intestinal barrier.

  2025cites this paper
• MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease

  2024cites this paper
• Tracking the Endosomal Escape of Nanoparticles in Live Cells Using a Triplex‐Forming Oligonucleotide

  2024cites this paper
• Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies

  2024cites this paper
• Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy

  2024cites this paper
• Acute Kidney Injury and Subsequent Cardiovascular Disease: Epidemiology, Pathophysiology, and Treatment.

  2024cites this paper
• How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease

  2024cites this paper
• Flavone improves liver damage in nicotine-exposed rats via the Nrf2/HO-1 pathway

  2024cites this paper
• Tulipalin A suppressed the pro-inflammatory polarization of M1 macrophage and mitigated the acute lung injury in mice via interference DNA binding activity of NF-κB.

  2024cites this paper
• A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine

  2024cites this paper
• Prolonged exposure to mercuric chloride induces oxidative stress–mediated nephrotoxicity in freshwater food fish Channa punctatus

  2024cites this paper
• Identification of renal protective gut microbiome derived-metabolites in diabetic chronic kidney disease: An integrated approach using network pharmacology and molecular docking

  2024cites this paper
• Exploration of Molecular Mechanisms of Immunity in the Pacific Oyster (Crassostrea gigas) in Response to Vibrio alginolyticus Invasion

  2024cites this paper
• Hypoxia-Induced Kidney Injury in Newborn Rats

  2023cites this paper
• CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation.

  2023cites this paper
• Protective effect of thymol on glycerol-induced acute kidney injury

  2023cites this paper
• Potential chemopreventive effects of Broccoli extract supplementation against 7, 12 dimethyl Benz(a)anthracene (DMBA) -induced toxicity in female rats

  2023cites this paper
• The Effects of Apigenin in the Treatment of Diabetic Nephropathy: A Systematic Review of Non-clinical Studies.

  2023cites this paper
• Role of p38 MAPK, Akt and NFκB in renoprotective effects of nebivolol on renal ischemia-reperfusion injury in rats

  2023cites this paper
• An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma

  2023cites this paper
• Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models

  2023cites this paper
• Casual Serum Triglyceride Concentrations and New-Onset Chronic Kidney Disease in the General Japanese Population: The Iki City Epidemiological Study of Atherosclerosis and Chronic Kidney Disease Study

  2023cites this paper
• Acid-sensing ion channel 1a exacerbates renal ischemia–reperfusion injury through the NF-κB/NLRP3 inflammasome pathway

  2023cites this paper
• Anti-Inflammatory Effects of Peripheral Dopamine

  2023cites this paper
• Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway.

  2023cites this paper
• Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications.

  2023cites this paper
• Diverse biological functions of the renin‐angiotensin system

  2023cites this paper
• The association between vitamin D3 deficiency and acute kidney injury in COVID-19 patients

  2023cites this paper
• Cofilin-1 induces acute kidney injury via the promotion of endoplasmic reticulum stress-mediated ferroptosis

  2023cites this paper
• Effects of oleanolic acid administration on renal NF-kB, IL-18, IL-6, YKL-40, and KIM-1 in experimental diabetic rats

  2023cites this paper
• Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

  2022cites this paper
• Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: PRO.

  2022cites this paper
• Oxymatrine Alleviates Gentamicin-Induced Renal Injury in Rats

  2022cites this paper
• Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

  2022cites this paper
• Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway

  2022cites this paper
• An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy.

  2022cites this paper
• Ovariectomy exacerbates glycerol-induced acute kidney injury in rats A ovariectomia intensifica a lesão renal aguda induzida pelo glicerol em ratas

  2022cites this paper
• ZnT8 Exerts Anti-apoptosis of Kidney Tubular Epithelial Cell in Diabetic Kidney Disease Through TNFAIP3-NF-κB Signal Pathways

  2022cites this paper
• Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

  2022cites this paper
• Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives.

  2022cites this paper
• New insight in the immune mechanisms in hyperuricemia after renal transplantation: a narrative review.

  2022cites this paper
• Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation

  2022cites this paper
• The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation

  2022cites this paper
• Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome

  2021cites this paper
• SIX1 Activation Is Involved in Cell Proliferation, Migration, and Anti-inflammation of Acute Ischemia/Reperfusion Injury in Mice

  2021cites this paper
• Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease

  2021cites this paper
• Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor.

  2021cites this paper
• Vitamin D deficiency in chronic kidney disease: myth or reality?

  2021cites this paper
• Anti-Inflammatory and Antioxidant Effects of Soroseris hirsuta Extract by Regulating iNOS/NF-κB and NRF2/HO-1 Pathways in Murine Macrophage RAW 264.7 Cells

  2021cites this paper
• Acute glucose fluctuation promotes RAGE expression via reactive oxygen species-mediated NF-κB activation in rat podocytes

  2021cites this paper
• The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats.

  2021cites this paper
• Exposure to High-Fat Style Diet Induced Renal and Liver Structural Changes, Lipid Accumulation and Inflammation in Intact and Ovariectomized Female Rats

  2021cites this paper
• Diallyl disulfide ameliorates methotrexate-induced nephropathy in rats: Molecular studies and network pharmacology analysis.

  2021cites this paper
• Clinical assessment of muscle condition in cats

  2021cites this paper
• Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease

  2021cites this paper
• Therapeutic potential of resveratrol in diabetic nephropathy according to molecular signaling.

  2021cites this paper
• INTRA-RENAL MODULATION OF NF-κB ACTIVITY ATTENUATES CARDIAC INJURY IN A SWINE MODEL OF CKD: A RENAL-CARDIO AXIS.

  2021cites this paper
• Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications

  2020cites this paper
• Oxymatrine Reverses Gentamicin-Induced Nephrotoxicity via Ameliorating the Immune Response for Gentamicin Therapy

  2020cites this paper
• Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy

  2020cites this paper
• Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function Through Regulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in an Atherosclerosis Model

  2020cites this paper
• TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.

  2020cites this paper
• Penehyclidine hydrochloride inhibits renal ischemia/reperfusion-induced acute lung injury by activating the Nrf2 pathway

  2020cites this paper
• Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice.

  2020cites this paper
• Erythropoietin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury via Inflammasome Suppression in Mice

  2020cites this paper
• The TLR4-MyD88-NF-κB pathway is involved in sIgA-mediated IgA nephropathy

  2020cites this paper
• Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent

  2020cites this paper
• Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications

  2020cites this paper
• Physical exercise associated with vitamin D chronic supplementation reduces kidney injury induced by monosodium glutamate.

  2020cites this paper
• The Deleterious Role of the Prostaglandin E2 EP3 Receptor in Angiotensin II Hypertension.

  2020cites this paper
• NF-κB and tPA Signaling in Kidney and Other Diseases

  2020cites this paper
• Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease

  2020cites this paper
• Vagus Nerve Stimulation Ameliorates Renal Ischemia-Reperfusion Injury through Inhibiting NF-κB Activation and iNOS Protein Expression

  2020cites this paper
• Plasma 25-Hydroxyvitamin D3 Concentrations and Risk of New-Onset Proteinuria in Patients With Hypertension.

  2020cites this paper
• A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease

  2020cites this paper
• Tiron protects against nicotine-induced lung and liver injury through antioxidant and anti-inflammatory actions in rats in vivo.

  2020cites this paper
• Running title: PHYSICAL EXERCISE AND VITAMIN D REDUCES KIDNEY INJURY Academy Section: HEALTH SCIENCES

  2020cites this paper
• Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.

  2020cites this paper
• Gene Regulatory Effect of Pyruvate Kinase M2 is Involved in Renal Inflammation in Type 2 Diabetic Nephropathy.

  2020cites this paper
• Regulation of dimethylarginine dimethylaminohydrolase 2 expression by NF-κB acetylation

  2020cites this paper
• Aerobic or resistance training improves autonomic control of circulation in oophorectomized rats with cardiometabolic dysfunctions: Impact on renal oxidative stress.

  2020cites this paper
• Ophiopogonin D of Ophiopogon japonicus ameliorates renal function by suppressing oxidative stress and inflammatory response in streptozotocin-induced diabetic nephropathy rats

  2020cites this paper
• Inflammatory Targets in Diabetic Nephropathy

  2020cites this paper
• The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model

  2019cites this paper
• Downregulation of TIMP2 attenuates sepsis-induced AKI through the NF-κb pathway.

  2019cites this paper
• Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways

  2019cites this paper
• Effect of Black and Green Tea on Experimental Sodium Oxalate-Induced Nephrotoxicity in Adult Male Mice

  2019cites this paper
• Neferine Attenuates Acute Kidney Injury by Inhibiting NF-κB Signaling and Upregulating Klotho Expression

  2019cites this paper
• The protective effect of miR-377 inhibitor against renal ischemia-reperfusion injury through inhibition of inflammation and oxidative stress via a VEGF-dependent mechanism in mice.

  2019cites this paper
• Polydatin prevents LPS-induced acute kidney injury through inhibiting inflammatory and oxidative responses.

  2019cites this paper
• The protective effect of cannabinoid type 2 receptor activation on renal ischemia–reperfusion injury

  2019cites this paper
• Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice

  2019cites this paper